Jesús Zurdo

Senior Director Strategic Innovation

Lonza Pharma & Biotech

Jesús Zurdo is Senior Director Strategic Innovation at Lonza Pharma & Biotech, where he coordinates technology partnerships relevant to the development and manufacturing of therapeutic products, including, biopharmaceuticals, ADCs, cell and gene therapy.

jz_2013_small_BW_3

He has an extensive trajectory in bioprocessing innovation and de-risking of biopharmaceutical drug development, being one of the early introducers of developability methodologies to biological drug development.  Jesús was cofounder of Zyentia, developing solutions to stabilise biological drugs and disease-modifying therapies for Parkinson’s, Alzheimer’s and type 2 diabetes. While at Zyentia he held various roles, including CSO and CEO, until the acquisition of the AggreSolve platform by Lonza in 2007. He was also cofounder and Scientific Advisor to Zapaloid, overseeing drug discovery programmes in neurodegeneration. Prior to his career in industry, Jesús held several research positions at the Universities of Oxford and Cambridge in the UK and at CBM-CSIC in Spain. He has a PhD in molecular biology from the Autonomous University of Madrid.